Preventive Medicine Doctors in Glendale, AZ Accepting Medicare

4 Preventive Medicine doctors found. Showing 1 - 4

Dr. Michael Lawrence Berman, DO Preventive Medicine - Undersea and Hyperbaric Medicine Medicare: Accepting Medicare Assignments Practice Location: 6320 W Union Hills Dr, Bldg A, Suite 140, Glendale, AZ 85308 Phone: 480-347-0844    Fax: 480-347-0885

Tabitha Woolpert, Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 22624 N 73rd Dr, Glendale, AZ 85310 Phone: 808-292-5367

Rosekamal Mckinney, M.D. Medicare: Accepting Medicare Assignments Practice Location: 13820 N 51st Ave, Suite 400, Glendale, AZ 85306 Phone: 602-938-2300

Dr. Anna Phuong Tran, M.D. Preventive Medicine - Occupational Medicine Medicare: Accepting Medicare Assignments Practice Location: 8811 N 51st Ave, Suite 107, Glendale, AZ 85302 Phone: 623-536-6788    Fax: 623-536-9288

News Archive

GWA Study helps scientists identify genetic variant that increases tuberculosis susceptibility in African populations

Scientists have identified a genetic variant which increases susceptibility to tuberculosis (TB) in African populations using a technique known as a genome-wide association (GWA) study. This is the first novel disease variant to be identified using this technique in Africans and demonstrates that such studies are viable in African populations, which have a high degree of genetic diversity.

Gamma globulin effective treatment for pinkeye

Gamma globulin, a type of antibody isolated from blood samples that used to be routinely given to health care workers and international travelers to protect them from infectious diseases, is a highly effective treatment for pinkeye with little apparent toxicity, according to a study by researchers at the University of Pittsburgh School of Medicine.

Ranbaxy receives tentative FDA approval for Fexofenadine hydrochloride tablets

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market the antihistamine Fexofenadine Hydrochloride Tablets, 30 mg, 60 mg, and 180 mg.

DNA-binding fluorescent dyes evaluate cytotoxicity in real-time during screening

High throughput screening of compounds in live cells is a powerful approach for discovering new drugs, but the potential for cell toxicity must be considered.

Read more Medical News

› Verified 6 days ago